To date, the use of albumin has been widely accepted for the following three indications: management of HRS, prevention of renal failure after SBP and prevention of renal injury following large volume paracentesis; however, many questions regarding the efficacy and safety of albumin remain. The gene discussed is ALB; the disease is kidney failure.